Skip to Main content Skip to Navigation
Journal articles

High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells

Abstract : Current chemotherapies for T cell acute lymphoblastic leukemia (T-ALL) efficiently reduce tumor mass. Nonetheless, disease relapse attributed to survival of preleukemic stem cells (pre-LSCs) is associated with poor prognosis. Herein, we provide direct evidence that pre-LSCs are much less chemosensitive to existing chemotherapy drugs than leukemic blasts because of a distinctive lower proliferative state. Improving therapies for TALL requires the development of strategies to target pre-LSCs that are absolutely dependent on their microenvironment. Therefore, we designed a robust protocol for high-throughput screening of compounds that target primary pre-LSCs maintained in a niche-like environment, on stromal cells that were engineered for optimal NOTCH1 activation. The multiparametric readout takes into account the intrinsic complexity of primary cells in order to specifically monitor pre-LSCs, which were induced here by the SCL/TAL1 and LMO1 oncogenes. We screened a targeted library of compounds and determined that the estrogen derivative 2-methoxyestradiol (2-ME2) disrupted both cell-autonomous and non-cell-autonomous pathways. Specifically, 2-ME2 abrogated pre-LSC viability and self-renewal activity in vivo by inhibiting translation of MYC, a downstream effector of NOTCH1, and preventing SCL/TAL1 activity. In contrast, normal hematopoietic stem/progenitor cells remained functional. These results illustrate how recapitulating tissue-like properties of primary cells in high-throughput screening is a promising avenue for innovation in cancer chemotherapy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [83 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-02353313
Contributor : Bastien Gerby <>
Submitted on : Wednesday, May 6, 2020 - 7:35:54 PM
Last modification on : Monday, November 9, 2020 - 6:18:02 PM

File

High-throughput screening iden...
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Bastien Gerby, Diogo F.T. Veiga, Jana Krosl, Sami Nourreddine, Julianne Ouellette, et al.. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells. Journal of Clinical Investigation, American Society for Clinical Investigation, 2016, 126 (12), pp.4569-4584. ⟨10.1172/JCI86489⟩. ⟨hal-02353313⟩

Share

Metrics

Record views

130

Files downloads

96